The Allergy Immunotherapies Market will register a CAGR of more than 7% by 2023

Thursday, December 6, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 5, 2018 /PRNewswire/ -- 112 pagesAbout this marketThe emerging drug development technologies is likely

to help the market grow during the forecast period. The recent advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more efficient immunotherapies for the treatment of various allergies. Technavio's analysts
have predicted that the allergy immunotherapies market will register a CAGR of more than 7% by 2023.Read the full report: https://www.reportlinker.com/p03952882 Market OverviewIncreasing prevalence of various types of allergiesThe increasing prevalence of various types of allergies across the globe is driving the allergy immunotherapies market. The growing occurrence of allergy is generated by the factors such as increasing pollution and augmented consumption of tobacco products like cigarettes, which is likely to boost the global allergy immunotherapy market.Unknown pathogenesisThe Unknown pathogenesis of various allergies is the major challenge faced by the global allergy immunotherapies market. The unclear cause of allergy results in physicians misdiagnosing the allergen, and as a result the treatment prescribed is not as effective as it should be, and it often leads to adverse events.For the detailed list of factors that will drive and challenge the growth of the allergy immunotherapies market during the 2019-2023, view our report.Competitive LandscapeThe market appears to be concentrated and with the presence of few companies including ALK and Allergy Therapeutics the competitive environment is quite intense. Factors such as the emerging drug development technologies and the technological advances in allergy diagnostics, will provide considerable growth opportunities to allergy immunotherapies manufactures. ALK, Allergy Therapeutics, Stallergenes Greer, HAL Allergy, and Merck are some of the major companies covered in this report.'With the presence of a considerable number of companies, this market appears to be fragmented. The current advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more effective immunotherapies for the treatment of various allergies. Several established allergy immunotherapy manufacturers are striving for their share of the global allergy immunotherapies market, and the new players must differentiate themselves to gain vital traction over their competitors.'Read the full report: https://www.reportlinker.com/p03952882 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-allergy-immunotherapies-market-will-register-a-cagr-of-more-than-7-by-2023-300760783.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store